+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID02237625

Observational Natural History Study of Adults and Children with Hypophosphatasia HPP

Led by Duke University · Updated on 2026-03-05

200

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Hypophosphatasia HPP is a rare inherited disorder affecting bone and teeth mineralization due to mutations in the ALPL gene, which lowers alkaline phosphatase levels. This condition can vary widely in severity, causing symptoms from stillbirth to early tooth loss and skeletal problems like rickets and osteomalacia. The disease shows different clinical forms depending on age at diagnosis and inheritance patterns that can be autosomal recessive or dominant. This observational study collects detailed clinical data from patients with HPP, including diagnosis, disease onset, progression, treatments, and outcomes. The study aims to build a comprehensive understanding of HPPs effects on bones, eyes, kidneys, muscles, and other systems, as well as explore complications such as cochlear implant failures and early menopause. Data will be gathered from current patients within the Duke University System. Participants will provide information about their medical history related to HPP over a long-term period of up to 100 years. Researchers will evaluate various clinical manifestations, treatment efficacy, potential long-term complications, and quality of life issues. The study involves ongoing collection and analysis of patient records and outcomes to improve knowledge and care strategies for HPP.

CONDITIONS

Brief Title

Natural History Study of Patients With Hypophosphatasia (HPP)

Research Team

J

Janet G Blount, BA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here